From Hepatitis C in Egypt
After being the highest country in the world with Hepatitis C prevalence, we are finally on track. Egypt is currently considered the global leader in the fight against Hepatitis C, providing an affordable and effective cure.
In the last year a million people were cured from Hepatitis C worldwide, 830,000 of them in Egypt, 600,000 using Pharco’s medicines.
Research
Through scientific research, Pharco succeeded to reach an effective and affordable cure.
Studies
were started in the three biggest liver centers in Egypt. The results were at an impressive cure rate of 97.5%, follow up showed no virus presence after 3 months from stopping the medicine.
For The Study Of Liver Diseases
Pharco presented at the annual San Francisco conference closing ceremony the abstract entitled: High Virologic Response Rate in Egyptian HCV-Genotype 4 Patients Treated with Ravidasvir (PPI-668) and Sofosbuvir: Results of a Large Multicenter Phase 3 Registrational Trial. Dr. Gamal Esmat, representing Pharco, was the first Arab to present in the closing ceremony, where the major treatment protocols for the upcoming year are agreed upon.
Now that we have a Cure that is affordable, we were able to treat the patients that were long waiting for a cure. Now it's Zero waiting time for patients and it’s a matter of knowing one’s infection status through screening.